Aroa Biosurgery Ltd (ARX)

Sydney
0.82
-0.01(-1.20%)
  • Volume:
    75,007
  • Bid/Ask:
    0.78/0.82
  • Day's Range:
    0.76 - 0.82

ARX Overview

Prev. Close
0.83
Day's Range
0.76-0.82
Revenue
29.2M
Open
0.82
52 wk Range
0.62-1.29
EPS
-0.02
Volume
75,007
Market Cap
284.46M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
199,390
P/E Ratio
-
Beta
-
1-Year Change
-35.83%
Shares Outstanding
342,724,208
Next Earnings Date
-
What is your sentiment on Aroa Biosurgery?
or
Vote to see community's results!

Aroa Biosurgery Ltd News

Aroa Biosurgery Ltd Company Profile

Aroa Biosurgery Ltd Company Profile

Employees
0
Market
Australia

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company’s products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellSell
Technical IndicatorsBuySellStrong SellNeutralStrong Sell
SummaryNeutralSellStrong SellSellStrong Sell